DIAMERIL 1MG TABLETS 30'S

glimepiride
sulphonyl urea blood sugar lowering agent
stimulates insulin release from pancreatic beta cells

Glimepiride is a sulfonylurea blood-sugar-lowering agent. It stimulates insulin release from pancreatic beta cells. This release mainly relies on improved responsiveness of these cells to physiological glucose stimulus. Glimepiride increases the normal action of insulin on peripheral glucose uptake. It also mim- ics such action as well as the glucose output of the liver. A single dose of Diameril can ensure good metabolic control over 24 hours. When patients don't respond sufficiently to the maximum dose of Diameril, a combination with an oral antidiabetic containing metformin or with insulin improves meta- bolic control.

treatment of non insulin dependent type II diabetes

Diameril tablets must be swallowed without chewing and with sufficient amounts of fluid (approximately 1/2 glass)

Ingredients

Glimepiride 1mg

Indication

Type 2 Diabetes Mellitus

Route Of Administration

Oral

Suitable For

Adults

Gender

Unisex

Formulation

Tablet

Storage Temperature

Below 25°C

Country Of Origin

Lebanon